Richard E. Lowenthal - PRESIDENT AND CEO, Director, 10%+ Owner at ARS Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director, 10%+ Owner
Stock Symbol
SPRY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Richard E. Lowenthal - trading volume in the past year for ARS Pharmaceuticals, Inc.

Holdings reported by Richard E. Lowenthal for ARS Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.32M $76.1M $17.64 Nov 12, 2024 Direct
Common Stock 3.41M $60.1M $17.64 Nov 12, 2024 By Spouse
Common Stock 1.4M $24.7M $17.64 Nov 12, 2024 By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
Common Stock 1.3M $22.9M $17.64 Nov 12, 2024 By Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020
Common Stock 1.25M $22M $17.64 Nov 12, 2024 By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Stock Option (right to buy) 34.5K Apr 23, 2024 By Spouse Common Stock

Transactions reported by Richard E. Lowenthal for ARS Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.